Clinical Trials Directory

Trials / Completed

CompletedNCT04914364

Balance Function in Patients Post Corona Virus Disease 2019 (COVID-19)

Describing Balance Function in Patients Post-COVID-19

Status
Completed
Phase
Study type
Observational
Enrollment
28 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The purpose of this study is to describe balance deficits in patients post COVID-19. The information the investigators learn may help influence balance training exercises for patients post-COVID-19. Participants will have a primary or secondary diagnosis of COVID-19 during hospitalization and off COVID-19 isolation and be receiving care in an acute inpatient hospital. Following consent, participants will complete balance assessments and questionnaires about balance and dizziness in a single session. Vital signs will be monitored during the session.The greatest risks of this study include shortness of breath, and a risk of falling or musculoskeletal soreness.These risks are no greater than those experienced during a usual physical therapy visit.

Detailed description

Heart rate (HR), respiratory rate (RR), blood pressure (BP), and oxygen saturation (SpO2) will be measured at rest and after all outcome measures are completed. Rate of Perceived Exertion (RPE) (0-10 per modified Borg scale) will be measured after each outcome measure. In addition, HR will be measured after each outcome measure. SpO2 will be continually monitored via pulse oximetry. Fraction of inspired oxygen (FiO2) will be titrated per MD orders. If SpO2 drops below MD-specified parameters, patients will first be given a 3-minute seated rest break. If SpO2 recovers above MD-specified parameters after rest break, activity will resume. If SpO2 remains below MD-specified parameters after rest break or continues to drop with activity, FiO2 will be titrated to maintain SpO2 within MD-specified parameters.

Conditions

Interventions

TypeNameDescription
OTHERBalance assessmentsThere is no formal intervention in this study. The investigators will only be completing balance assessments with no follow-up visit.

Timeline

Start date
2021-07-23
Primary completion
2022-06-22
Completion
2022-06-22
First posted
2021-06-04
Last updated
2024-09-19
Results posted
2024-09-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04914364. Inclusion in this directory is not an endorsement.